Trial · NCT04251585
Results by group124
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 124
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Safety Measured by Count of Safety Events | Low Insulin | 0 | Participants | ||
| Safety Measured by Count of Safety Events | Medium Insulin | 0 | Participants | ||
| Safety Measured by Count of Safety Events | High Insulin | 0 | Participants | ||
| Safety Measured by Count of Safety Events | Placebo | 0 | Participants | ||
| Safety Measured by Fasting Glucose | Low Insulin | -3.8 | 95% Confidence Interval -6.9 to -1.0 | mg/dL | |
| Safety Measured by Fasting Glucose | Medium Insulin | -1.3 | 95% Confidence Interval -6.8 to 4.2 | mg/dL | |
| Safety Measured by Fasting Glucose | High Insulin | -5.9 | 95% Confidence Interval -10 to -1.8 | mg/dL | |
| Safety Measured by Fasting Glucose | Placebo | -3.8 | 95% Confidence Interval -9.8 to 2.1 | mg/dL | |
| Safety Measured by Body Weight | Low Insulin | -0.63 | 95% Confidence Interval -1.8 to 0.50 | pounds | |
| Safety Measured by Body Weight | Medium Insulin | 0.34 | 95% Confidence Interval -1.6 to 2.3 | pounds | |
| Safety Measured by Body Weight | High Insulin | -0.33 | 95% Confidence Interval -1.9 to 1.3 | pounds | |
| Safety Measured by Body Weight | Placebo | -0.55 | 95% Confidence Interval -3.0 to 1.9 | pounds | |
| Safety Measured by the Number of Serious Adverse Events (SAE) and Adverse Events (AE) | Low Insulin | SAE | 0 | Standard Deviation 0 | number of events |
| Safety Measured by the Number of Serious Adverse Events (SAE) and Adverse Events (AE) | Medium Insulin | SAE | 0 | Standard Deviation 0 | number of events |
| Safety Measured by the Number of Serious Adverse Events (SAE) and Adverse Events (AE) | High Insulin | SAE | 0 | Standard Deviation 0 | number of events |
| Safety Measured by the Number of Serious Adverse Events (SAE) and Adverse Events (AE) | Placebo | SAE | 0 | Standard Deviation 0 | number of events |
| Safety Measured by the Number of Serious Adverse Events (SAE) and Adverse Events (AE) | Low Insulin | AE | 2.8 | Standard Deviation 1.2 | number of events |
| Safety Measured by the Number of Serious Adverse Events (SAE) and Adverse Events (AE) | Medium Insulin | AE | 5.0 | Standard Deviation 2.8 | number of events |
| Safety Measured by the Number of Serious Adverse Events (SAE) and Adverse Events (AE) | High Insulin | AE | 2.0 | Standard Deviation 3.8 | number of events |
| Safety Measured by the Number of Serious Adverse Events (SAE) and Adverse Events (AE) | Placebo | AE | 3.0 | Standard Deviation 0.89 | number of events |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04251585/results